Karen A. Flynn's Insider Trades & SAST Disclosures
Karen A. Flynn's most recent trade in Sotera Health Co was a trade of 19,132 Common Stock, $0.01 par value per share ("Common Stock") done . Disclosure was reported to the exchange on May 22, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Karen A. Flynn.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sotera Health Co | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 19,132 | 39,221 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Quanterix Corp | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 15,821 | 15,821 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,435 | 33,840 (0%) | 0% | 0 | Common Stock | |
| Sotera Health Co | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,089 | 20,089 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Quanterix Corp | Flynn Karen A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,412 | 6,412 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Karen Flynn A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 2,947 | 26,405 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2023 | 6,993 | 24,339 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 12,124 | 12,124 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 8,083 | 22,540 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 12.86 per share. | 03 Jan 2023 | 918 | 23,458 (0%) | 0% | 12.9 | 11,805 | Common Stock |
| Catalent Inc. | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 4,149 | 17,346 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 10.48 per share. | 03 Oct 2022 | 1,066 | 14,457 (0%) | 0% | 10.5 | 11,172 | Common Stock |
| Catalent Inc. | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 245 | 13,197 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 16.79 per share. | 01 Jul 2022 | 164 | 13,391 (0%) | 0% | 16.8 | 2,754 | Common Stock |
| Quanterix Corp | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 19,841 | 19,841 | - | - | Stock Option (right to buy) | |
| Quanterix Corp | Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 13,227 | 13,227 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Karen A. Flynn | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 116.64 per share. | 10 Jan 2022 | 2,472 | 33,223 (0%) | 0% | 116.6 | 288,334 | Common Stock |
| Catalent Inc. | Karen A. Flynn | Pres. Biologics & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2021 | 5,953 | 5,953 | - | - | Options to purchase Common Stock | |
| Catalent Inc. | Karen A. Flynn | Pres. Biologics & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2021 | 1,151 | 35,695 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Karen A. Flynn | Pres. Biologics & CCO | Sale of securities on an exchange or to another person at price $ 112.14 per share. | 11 Jan 2021 | 1,378 | 35,644 (0%) | 0% | 112.1 | 154,529 | Common Stock |
| Catalent Inc. | Karen A. Flynn | Pres. Biologics & CCO | Sale of securities on an exchange or to another person at price $ 112.50 per share. | 11 Jan 2021 | 1,100 | 34,544 (0%) | 0% | 112.5 | 123,750 | Common Stock |
| Catalent Inc. | Karen A. Flynn | Pres. Biologics & CCO | Sale of securities on an exchange or to another person at price $ 104.42 per share. | 04 Jan 2021 | 99 | 37,022 (0%) | 0% | 104.4 | 10,338 | Common Stock |
| Catalent Inc. | Karen A. Flynn | Pres. Biologics & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2020 | 8,005 | 8,005 | - | - | Options to purchase Common Stock | |
| Catalent Inc. | Karen A. Flynn | Pres. Biologics & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2020 | 1,476 | 37,121 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges